XML 35 R21.htm IDEA: XBRL DOCUMENT
v3.22.1

Fair Value of Financial Instruments | 3 Months Ended
--- | ---
Apr. 01, 2022
Fair Value Disclosures [Abstract] |
Fair Value of Financial Instruments | Fair Value of Financial Instruments The Company measures and records financial instruments at fair value. A hierarchy is used for those instruments measured at fair value that distinguishes between assumptions based on market data (observable inputs) and the Company’s assumptions (unobservable inputs). The hierarchy consists of three levels: Level 1 — Quoted market prices in active markets for identical assets and liabilities; Level 2 — Inputs other than Level 1 inputs that are either directly or indirectly observable; and Level 3 — Unobservable inputs developed using estimates and assumptions developed by the Company, which reflect those that a market participant would use. The following table summarizes the financial instruments measured at fair value in the Consolidated Balance Sheets as of April 1, 2022 and December 31, 2021:
(Thousands) |  | Total Carrying Value in the Consolidated Balance Sheets |  | Quoted Prices in Active Markets for Identical Assets (Level 1) |  | Significant Other Observable Inputs (Level 2) |  | Significant Unobservable Inputs (Level 3)
| 2022 |  | 2021 |  | 2022 |  | 2021 |  | 2022 |  | 2021 |  | 2022 |  | 2021
Financial Assets |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Deferred compensation investments |  | $ | 3,675 |  |  | $ | 4,426 |  |  | $ | 3,675 |  |  | $ | 4,426 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |
Foreign currency forward contracts |  | 2,885 |  |  | 3,368 |  |  | — |  |  | — |  |  | 2,885 |  |  | 3,368 |  |  | — |  |  | — |
Interest rate swap |  | 3,227 |  |  | — |  |  | — |  |  | — |  |  | 3,227 |  |  | — |  |  | — |  |  | — |
Precious metal swaps |  | — |  |  | 116 |  |  | — |  |  | — |  |  | — |  |  | 116 |  |  | — |  |  | — |
Total |  | $ | 9,787 |  |  | $ | 7,910 |  |  | $ | 3,675 |  |  | $ | 4,426 |  |  | $ | 6,112 |  |  | $ | 3,484 |  |  | $ | — |  |  | $ | — |
Financial Liabilities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Deferred compensation liability |  | $ | 3,675 |  |  | $ | 4,426 |  |  | $ | 3,675 |  |  | $ | 4,426 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |
Foreign currency forward contracts |  | 480 |  |  | 136 |  |  | — |  |  | — |  |  | 480 |  |  | 136 |  |  | — |  |  | — |
Precious metal swaps |  | 321 |  |  | 24 |  |  | — |  |  | — |  |  | 321 |  |  | 24 |  |  | — |  |  | — |
Total |  | $ | 4,476 |  |  | $ | 4,586 |  |  | $ | 3,675 |  |  | $ | 4,426 |  |  | $ | 801 |  |  | $ | 160 |  |  | $ | — |  |  | $ | — |
The Company uses a market approach to value the assets and liabilities for financial instruments in the table above. Outstanding contracts are valued through models that utilize market observable inputs, including both spot and forward prices, for the same underlying currencies, metals, and interest rates. The carrying values of the other working capital items and debt in the Consolidated Balance Sheets approximate fair values as of April 1, 2022 and December 31, 2021. The Company's deferred compensation investments and liabilities are based on the fair value of the investments corresponding to the employees’ investment selections, primarily in mutual funds, based on quoted prices in active markets for identical assets. Deferred compensation investments are primarily presented in Other assets. Deferred compensation liabilities are primarily presented in Other long-term liabilities.

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration